financetom
Business
financetom
/
Business
/
Airbus sees 820 jet deliveries in 2025, unveils new charges
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Airbus sees 820 jet deliveries in 2025, unveils new charges
Feb 19, 2025 10:01 PM

Feb 20 (Reuters) - Airbus predicted a 7% rise

in commercial deliveries to around 820 jets in 2025 and

confirmed a delay in its A350 freighter model as it posted lower

core annual operating earnings broadly in line with

expectations.

Europe's largest aerospace group also took a fresh charge of

300 million euros ($312.63 million) for its troubled Space

business, while flagging potential risks to the long-term future

of its slow-selling A400M military transport aircraft.

($1 = 0.9596 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Polestar Q3 Loss Widens, Revenue Rises; Shares Down Pre-Bell
Polestar Q3 Loss Widens, Revenue Rises; Shares Down Pre-Bell
Nov 12, 2025
07:35 AM EST, 11/12/2025 (MT Newswires) -- Polestar Automotive (PSNY) reported a Q3 net loss Wednesday of $365.3 million, widening from a loss of $322.8 million a year earlier. A single analyst polled by FactSet expected a loss of $364.6 million. Revenue for the quarter ended Sept. 30 was $748 million, up from $550 million a year earlier. A single...
BRIEF-Reed's Inc Applied To List Shares On NYSE American
BRIEF-Reed's Inc Applied To List Shares On NYSE American
Nov 12, 2025
Nov 12 (Reuters) - Reed's Inc: * REED'S INC - APPLIED TO LIST SHARES ON NYSE AMERICAN - SEC FILING * REED'S INC - FILES FOR OFFERING 1.3 MILLION SHARES OF COMMON STOCK - SEC FILING Source text: Further company coverage: ...
Alkermes' narcolepsy drug meets main goal in a mid-stage trial
Alkermes' narcolepsy drug meets main goal in a mid-stage trial
Nov 12, 2025
Nov 12 (Reuters) - Alkermes ( ALKS ) said on Wednesday its experimental narcolepsy drug met the main goals in a mid-stage study. (Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D'Silva) ...
Virtus Investment Partners Reports Lower Preliminary Assets Under Management for October
Virtus Investment Partners Reports Lower Preliminary Assets Under Management for October
Nov 12, 2025
07:36 AM EST, 11/12/2025 (MT Newswires) -- Virtus Investment Partners ( VRTS ) said Wednesday preliminary assets under management totaled $166.20 billion as of Oct. 31, down from $169.33 billion a month earlier. The company said the decline was attributed to market performance and net outflows in US retail funds, retail separate accounts, and institutional accounts, partially offset by positive...
Copyright 2023-2026 - www.financetom.com All Rights Reserved